Real-Life Tolerability and Effectiveness of Adalimumab Biosimilar in Rheumatoid Arthritis: ASPIRE Registry Data

INTRODUCTION: The TNF-α blocker adalimumab is a well-proven therapy for rheumatoid arthritis (RA). A biosimilar adalimumab (ZRC-3197; Exemptia™), a ‘fingerprint match’ to reference adalimumab, has been approved for prescription in India since 2014. Here, we report on the effectiveness and tolerabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Sanjiv, Kaushik, Viswanath V., Jain, Rahul, Rao, Vijay, Gharia, Mihir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702582/
https://www.ncbi.nlm.nih.gov/pubmed/31254222
http://dx.doi.org/10.1007/s40744-019-0166-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702582/
https://www.ncbi.nlm.nih.gov/pubmed/31254222
http://dx.doi.org/10.1007/s40744-019-0166-2

Ejemplares similares